$URGN

$33.91 -$0.13 (0.38%) Close

$URGN Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 48.9M shares outstanding

Who owns URGN?

By type of holder

Institutions 86.7% Insiders 0.0% Everyone else 13.3%

Concentration Top 10 holders own 47.9%

RTW Investments, LP 9.3% · BlackRock, Inc. 6.6%

Institutional ownership

86.7%

-8.3 pts vs last qtr

Institutional holders

188

+15 vs last qtr

Net shares bought

−4.0M

by institutions in Q2 2026

New / sold out

40 / 25

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Point72 Asset Management, L.P. NEW +1.5M
SG Americas Securities, LLC +395.1K

Biggest sellers in Q2 2026

Toronto Dominion Bank SOLD OUT −2.6M
Paradigm Biocapital Advisors LP SOLD OUT −1.7M

Who is planning to sell?

Notices of proposed sale, last 12 months

$4.79M

10 notices from 4 people

Shares covered

123.8K

0.25% of the company

Arranged in advance

27%

of the value is under a 10b5-1 plan

Under a 10b5-1 plan No plan

Largest proposed sellers

Schoenberg Mark Officer $4.59M
Christopher Degnan Officer $89.6K

Every notice on Red Flags →

A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.

Is your stake being diluted?

There are not yet two fiscal years of reported share counts for UroGen Pharma Ltd..

How patient are the owners?

Institutional shares by how long they've been held

5+ years28% 3–5 years14% 1–3 years31% Under 1 year27%

Quarterly turnover

14.6%

of institutional shares changed hands

Top 10 managers, median time held

1.8 years

Super Investors

Investment managers reporting URGN on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
RI RTW Investments, LP	4.5M	9.30%	Unchanged	2021	1.4%
Shares held by quarter Peak holding4.5M (Q2'25) Change over 8 quarters+756.5K Share of the company9.300% RTW Investments, LP's full portfolio →
B BlackRock, Inc.	3.2M	6.55%	+355.9K (+12.5%)	≤2021	0.0%
Shares held by quarter Peak holding3.2M (Q2'26) Change over 8 quarters+703.5K Share of the company6.550% BlackRock, Inc.'s full portfolio →

RTW Investments, LP

4.5M

% of company

9.30%

Change vs last qtr

Unchanged

Held since

2021

BlackRock, Inc.

3.2M

% of company

6.55%

Change vs last qtr

+355.9K (+12.5%)

Held since

≤2021

28 more super investors behind a free account

See every manager holding UroGen Pharma Ltd., how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting URGN on Form N-PORT; together they hold 3.7% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
SC Small Cap Growth Fund American Century Mutual Funds, Inc.	$33.5M	875.0K	1.79%	0.60%	July 31, 2026
VR Vanguard Russell 2000 Index Fund Vanguard Scottsdale Funds	$5.82M	206.8K	0.42%	0.03%	May 31, 2026

Small Cap Growth Fund

American Century Mutual Funds, Inc.

Position value

$33.5M

% of company

1.79%

% of the fund

0.60%

As of

July 31, 2026

Vanguard Russell 2000 Index Fund

Vanguard Scottsdale Funds

Position value

$5.82M

% of company

0.42%

% of the fund

0.03%

As of

May 31, 2026

23 more funds behind a free account

See every fund holding UroGen Pharma Ltd. and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
FC Fred Cohen 5%+ holder 13D · 1.9%	838.6K	1.72%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company1.720% Disclosed stake13D · 1.9% View the 13D/G filing →
MC Monograph Capital Holdings Advisors, LLC 5%+ holder 13D · 1.8%	838.6K	1.72%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company1.720% Disclosed stake13D · 1.8% View the 13D/G filing →

Fred Cohen

5%+ holder13D · 1.9%

838.6K

% of company

1.72%

Change vs last qtr

—

Held since

—

Monograph Capital Holdings Advisors, LLC

5%+ holder13D · 1.8%

838.6K

% of company

1.72%

Change vs last qtr

—

Held since

—

2 more holders behind a free account

See every insider and 5%+ holder of UroGen Pharma Ltd..

Comments